Chimerix Net Borrowings Over Time
| CMRX Stock | USD 0.90 0.01 1.12% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Chimerix Performance and Chimerix Correlation. Chimerix |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chimerix. If investors know Chimerix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chimerix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.93) | Revenue Per Share 0.002 | Quarterly Revenue Growth 1.364 | Return On Assets (0.30) | Return On Equity (0.49) |
The market value of Chimerix is measured differently than its book value, which is the value of Chimerix that is recorded on the company's balance sheet. Investors also form their own opinion of Chimerix's value that differs from its market value or its book value, called intrinsic value, which is Chimerix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chimerix's market value can be influenced by many factors that don't directly affect Chimerix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chimerix's value and its price as these two are different measures arrived at by different means. Investors typically determine if Chimerix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chimerix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Net Borrowings Analysis
Compare Chimerix and related stocks such as Assembly Biosciences, Spero Therapeutics, and Achilles Therapeutics PLC Net Borrowings Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASMB | 419.4 K | 419.4 K | 480 K | 480 K | 480 K | 480 K | 480 K | 480 K | 480 K | 480 K | 480 K | 480 K | 480 K | 552.1 K | 494.7 K |
| SPRO | (54.5 M) | (54.5 M) | (54.5 M) | (54.5 M) | (54.5 M) | (54.5 M) | (54.5 M) | (54.5 M) | (54.5 M) | (54.5 M) | (54.5 M) | (54.5 M) | (54.5 M) | (49 M) | (51.5 M) |
| CTMX | (1.3 M) | (1.3 M) | (1.3 M) | (1.3 M) | (1.3 M) | (3.1 M) | 78 K | 78 K | 78 K | 78 K | 78 K | 78 K | 78 K | 89.7 K | 94.2 K |
| NXTC | (140 K) | (140 K) | (140 K) | (140 K) | (140 K) | (140 K) | (140 K) | (140 K) | (400 K) | 4.5 M | (1.5 M) | (3.5 M) | (3.5 M) | (3.1 M) | (3 M) |
| DAWN | 1000 K | 1000 K | 1000 K | 1000 K | 1000 K | 1000 K | 1000 K | 1000 K | 1000 K | 1000 K | 1000 K | 1000 K | 1000 K | 900 K | 800 K |
| XFOR | 6 M | 6 M | 6 M | 6 M | 6 M | 6 M | 6 M | 6 M | 3.5 M | 481 K | 12.4 M | (795 K) | (795 K) | (715.5 K) | (679.7 K) |
| MREO | 3.5 M | 3.5 M | 3.5 M | 3.5 M | 3.5 M | 3.5 M | 3.5 M | 20 M | 455 K | (2.2 M) | 22.5 M | (692 K) | (937 K) | (843.3 K) | (801.1 K) |
| TERN | 58 K | 58 K | 58 K | 58 K | 58 K | 58 K | 58 K | 58 K | 58 K | 58 K | 16.9 M | (12.9 M) | 243 K | 218.7 K | 207.8 K |
Chimerix and related stocks such as Assembly Biosciences, Spero Therapeutics, and Achilles Therapeutics PLC Net Borrowings description
The difference between the amount of new debt a company has taken on and the amount of debt it has paid off during a given period.My Equities
My Current Equities and Potential Positions
| Chimerix | CMRX |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | North Carolina; U.S.A |
| Exchange | NASDAQ Exchange |
USD 0.9
Additional Tools for Chimerix Stock Analysis
When running Chimerix's price analysis, check to measure Chimerix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chimerix is operating at the current time. Most of Chimerix's value examination focuses on studying past and present price action to predict the probability of Chimerix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chimerix's price. Additionally, you may evaluate how the addition of Chimerix to your portfolios can decrease your overall portfolio volatility.